Global Ulcerative Colitis Market Growth of 6.6% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AbbVie, Merck, Abbott - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Ulcerative Colitis Market 2016-2020" report to their offering.

The global ulcerative colitis market is forecast to grow at a CAGR of 6.6% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.

The report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

Questions Answered:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned Include:

  • AbbVie
  • Janssen Biotech
  • Merck
  • Takeda Pharmaceuticals
  • Abbott
  • Ajinomoto Pharmaceuticals
  • Amgen
  • Arena Pharmaceuticals
  • AstraZeneca
  • Astellas Pharma
  • Avaxia Biologics
  • BioLineRx
  • Celgene
  • Cosmo Pharmaceuticals
  • Eisai
  • Kissei Pharmaceutical
  • Kyowa Hakko Kirin
  • Lipid Therapeutics
  • Meda
  • Shield Therapeutics
  • Shire Pharmaceuticals
  • Sterna Biologicals
  • Tillotts Pharma
  • TopiVert
  • UCB
  • Zeria Pharmaceutical

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by molecule type

PART 09: Market segmentation by dosage form

PART 10: Market segmentation by route of administration

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Appendix

PART 19: About the Author

For more information visit http://www.researchandmarkets.com/research/hlfghc/global_ulcerative

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716